← Back
$BTAI All transactions

BioXcel Therapeutics, Inc.

A

$ Value

$0

Shares

9,000

Price

$0

Filed

Aug 5

Insider

Name

Steinhart Richard I

Title

Chief Financial Officer

CIK

0001293789

Roles

Officer

Transaction Details

Transaction Date

2025-08-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,000

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | On August 1, 2025 (the "Grant Date"), the Reporting Person was granted 9,000 RSUs, vesting as to 100% on or within thirty (30) days of 9 months from the Grant Date, subject to the Reporting Person's continued employment with the Issuer or a subsidiary of the Issuer on such date.

Filing Info

Accession No.

0001104659-25-074372

Form Type

4

Issuer CIK

0001720893

Steinhart Richard I's History

Date Ticker Type Value
2026-03-15 BTAI M
2026-03-15 BTAI M $0
2026-03-14 BTAI M
2026-03-14 BTAI M $0
2026-01-01 BTAI A $0
2025-12-15 BTAI M
2025-12-15 BTAI M $0
2025-12-14 BTAI M
2025-12-14 BTAI M $0
2025-09-15 BTAI M

Other Insiders at BTAI (90d)

Insider Bought Sold Last
Steinhart Richard I
Chief Financial Officer
2026-03-15
Yocca Frank
Chief Scientific Officer
2026-03-15
Mehta Vimal
CEO and President
2026-03-15
Rodriguez Javier
See Remarks
2026-03-15